Metabolism of 5x Reduced Androgens by Various Tissues of the Male Rat
|
|
0
|
1080
|
May 4, 2010
|
Mutagenesis of 3a-Hydroxysteroid Dehydrogenase Reveals a “Push−Pull” Mechanism for Proton Transfer in Aldo&am
|
|
2
|
1332
|
May 4, 2010
|
Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain.
|
|
0
|
1228
|
May 3, 2010
|
Characterization of 17a-hydroxysteroid dehydrogenase activity (17aHSD) and its involvement in the biosynthesi
|
|
0
|
1831
|
May 3, 2010
|
The distribution, nuclear uptake and metabolism of [3H]dihydrotestosterone in the brain, pituitary gland and genital tract of th
|
|
0
|
1186
|
May 2, 2010
|
Pretreatments with 5 alpha-dihydrotestosterone and the uptake of testosterone by cell nuclei in the brains of male rhesus monkey
|
|
0
|
1245
|
May 2, 2010
|
Testosterone and erectile function recovery after radiothera
|
|
3
|
4775
|
April 30, 2010
|
Intramuscular administration of 5-dihydrotestosterone heptanoate: changes in urinary hormone profile
|
|
0
|
1476
|
April 29, 2010
|
3a-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavi
|
|
6
|
2201
|
April 28, 2010
|
Opposing Changes in 3a;-Hydroxysteroid Dehydrogenase Oxidative and Reductive Activities in Rat Leydig Cells during Puber
|
|
0
|
1210
|
April 28, 2010
|
High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen recep
|
|
0
|
1245
|
April 28, 2010
|
The testosterone metabolite and neurosteroid 3alpha-androstanediol may mediate t
|
|
0
|
1154
|
April 27, 2010
|
Rat 3-Hydroxysteroid Dehydrogenase: To Oxidize or Reduce, that Is the Question
|
|
0
|
1379
|
April 27, 2010
|
DHT is a Peripheral Paracrine Hormone
|
|
0
|
1237
|
April 27, 2010
|
fin study with testosterone
|
|
1
|
1217
|
April 24, 2010
|
Solution to brain fog, Maybe
|
|
2
|
1340
|
April 24, 2010
|
5ar activity quadrupled with LH stimulation (in mice)
|
|
0
|
1070
|
April 23, 2010
|
USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A 5-HT1A AGONIST, IN THE TREATMENT OF SEXUAL DYSFUNCTION
|
|
0
|
1294
|
April 21, 2010
|
DHT is responsible for stimulation of VGEF
|
|
0
|
1165
|
April 18, 2010
|
How is communication mediated within the male reproductive system?
|
|
0
|
1205
|
April 16, 2010
|
Probable effects of Human Growth Hormone on isolated human penile tissue
|
|
1
|
1552
|
April 15, 2010
|
GSK funded study on 5ARI's effects on bone mineral density, sexual behaviour, PSA, etc
|
|
4
|
2093
|
April 11, 2010
|
(WO/2008/054214) USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A PDE5 INHIBITOR, IN THE TREATMENT OF SEXUAL DYSF
|
|
10
|
4264
|
April 7, 2010
|
Nuerosteriods and finasteride
|
|
0
|
1221
|
April 4, 2010
|
Emerging Roles for Neurosteroids in Sexual Behavior and Function
|
|
4
|
1964
|
March 30, 2010
|
GABA-B Agonist Reverses Negative Feedback Effect of Testosterone on GnRH and LH Secretion in Male Sheep
|
|
1
|
3560
|
March 12, 2010
|
Oral DHEA for increasing Adiol G
|
|
10
|
4656
|
February 23, 2010
|
Normal and elevated 3 alpha-androstanediol glucuronide concentrations and correlation with degree of adrenal/androgen levels
|
|
3
|
1574
|
February 9, 2010
|
[Age-related changes in plasma androstanediol glucuronide in men]
|
|
0
|
1303
|
February 6, 2010
|
Use of 5alpha-androstanedione to increase DHT LEVELS...READ PLEASE!
|
|
10
|
4368
|
February 5, 2010
|